STİNG (stimulatorof interferon genes protein) in systemic Vasculitis
Project no. 32411 · Status: Kapanmış (Yayın bekleniyor) · 2024
Summary
<p class="ql-align-justify">Gain-of-function mutations in transmembrane protein 173 (TMEM173), which encodes the stimulator of interferon genes (STING), have been identified as chronic activation of the interferon pathway, leading to the development of autoinflammatory syndrome (SAVI), an infantile vasculopathy affecting mostly the skin, lungs, and central nervous system. More recent reports have demonstrated a broader phenotypic and disease-onset spectrum, including infectious, autoimmune, and renal manifestations. Mouse model experiments have demonstrated increased cGAMP levels and an IFN-I signature in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a group of life-threatening diseases whose underlying pathogenic mechanisms remain poorly understood. Elucidating the etiology and pathogenesis of AAV is essential for the development of new biomarkers and targeted therapeutic agents. In our study, we aimed to evaluate the presence of TMEM173 mutation in AAVs seen in the adult age group and especially with interstitial fibrosis and therefore whether the type 1 interferon pathway is active. A total of 90 patients with previously diagnosed <span style="color: black;">Microscopic polyangiitis (</span>MPA) (n: 30), Granulomatosis with polyangiitis (GPA) (n: 20), Takayasu (n: 20), and healthy controls (n: 20) were included in the study at Ege University Faculty of Medicine Hospital. STING (TMEM 173 mutation) was evaluated by DNA sequence analysis in blood samples collected from 89 patients (GPA, MPA, Takayasu) during follow-up between 2004 and 2025 and 20 healthy controls. A total of 90 patients with previously diagnosed MPA (n: 30, female: median age: ), GPA (n: 20, female: median age: ), Takayasu (n: 20, female: median age: ), and healthy controls (n: 20, female: median age: ) were included in the study at Ege University Faculty of Medicine Hospital. TMEM173 gene analysis was performed in the blood of 89 patients using DNA sequence analysis. TMEM173 mutations were detected in two patients: one Takayasu and one GPA. No other study in the literature has investigated the presence of STING using TMEM173 mutation analysis in systemic vasculitis; our study is the first in this regard. In conclusion, although TMEM173 mutations are rare, the phenotypes of positive cases suggest that the STING pathway may play a role, particularly in AAV with pulmonary involvement and certain Takayasu arteritis subtypes. This pathway stands out as an important area of research for biomarker and targeted therapy development. The findings are important in terms of shedding light on future studies. Future studies with larger cohorts, interferon signatures, and functional analyses may further clarify the role of TMEM173 variants in the pathogenesis of vasculitis.</p><p class="ql-align-justify"></p>